John Ford is the founder of Enterprise Therapeutics. Enterprise Therapeutics has raised $41M in total funding. Latest round: Series B.
John Ford is the CEO of Enterprise Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for respiratory diseases. He led the company through its Series B funding round of £29 million ($41 million) in 2018. Ford also previously founded Dezima.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide